Literature DB >> 23277542

Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity.

Qin Zhang1, Erick Spears, David N Boone, Zhaoliang Li, Mark A Gregory, Stephen R Hann.   

Abstract

The oncogenic transcription factor c-Myc causes transformation and tumorigenesis, but it can also induce apoptotic cell death. Although tumor suppressors are necessary for c-Myc to induce apoptosis, the pathways and mechanisms are unclear. To further understand how c-Myc switches from an oncogenic protein to an apoptotic protein, we examined the mechanism of p53-independent c-Myc-induced apoptosis. We show that the tumor suppressor protein ARF mediates this switch by inhibiting ubiquitylation of the c-Myc transcriptional domain (TD). Whereas TD ubiquitylation is critical for c-Myc canonical transcriptional activity and transformation, inhibition of ubiquitylation leads to the induction of the noncanonical c-Myc target gene, Egr1, which is essential for efficient c-Myc-induced p53-independent apoptosis. ARF inhibits the interaction of c-Myc with the E3 ubiquitin ligase Skp2. Overexpression of Skp2, which occurs in many human tumors, inhibits the recruitment of ARF to the Egr1 promoter, leading to inhibition of c-Myc-induced apoptosis. Therapeutic strategies could be developed to activate this intrinsic apoptotic activity of c-Myc to inhibit tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23277542      PMCID: PMC3549076          DOI: 10.1073/pnas.1208334110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Skp2 regulates Myc protein stability and activity.

Authors:  So Young Kim; Andreas Herbst; Kathryn A Tworkowski; Simone E Salghetti; William P Tansey
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

3.  p19ARF directly and differentially controls the functions of c-Myc independently of p53.

Authors:  Ying Qi; Mark A Gregory; Zhaoliang Li; Jeffrey P Brousal; Kimberly West; Stephen R Hann
Journal:  Nature       Date:  2004-09-08       Impact factor: 49.962

4.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

Review 5.  Regulation of gene transcription by the oncoprotein MYC.

Authors:  Bernhard Lüscher; Jörg Vervoorts
Journal:  Gene       Date:  2011-12-28       Impact factor: 3.688

6.  Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins.

Authors:  G D Spotts; S V Patel; Q Xiao; S R Hann
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

7.  Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells.

Authors:  Sang Hyun Lee; Frank McCormick
Journal:  J Mol Med (Berl)       Date:  2004-12-17       Impact factor: 4.599

8.  The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription.

Authors:  Natalie von der Lehr; Sara Johansson; Siqin Wu; Fuad Bahram; Alina Castell; Cihan Cetinkaya; Per Hydbring; Ingrid Weidung; Keiko Nakayama; Keiichi I Nakayama; Ola Söderberg; Tom K Kerppola; Lars-Gunnar Larsson
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

9.  Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.

Authors:  S E Salghetti; S Y Kim; W P Tansey
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

10.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.

Authors:  Markus Welcker; Amir Orian; Jianping Jin; Jonathan E Grim; Jonathan A Grim; J Wade Harper; Robert N Eisenman; Bruce E Clurman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

View more
  22 in total

1.  Deubiquitinating c-Myc: USP36 steps up in the nucleolus.

Authors:  Xiao-Xin Sun; Rosalie C Sears; Mu-Shui Dai
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

3.  Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.

Authors:  X Meng; N R Carlson; J Dong; Y Zhang
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

4.  Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.

Authors:  Franz X Schaub; Varsha Dhankani; Ashton C Berger; Mihir Trivedi; Anne B Richardson; Reid Shaw; Wei Zhao; Xiaoyang Zhang; Andrea Ventura; Yuexin Liu; Donald E Ayer; Peter J Hurlin; Andrew D Cherniack; Robert N Eisenman; Brady Bernard; Carla Grandori
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

5.  MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells.

Authors:  Yuxin Yang; Qiuyu Meng; Chen Wang; Xiaonan Li; Yanan Lu; Xiaoru Xin; Qidi Zheng; Dongdong Lu
Journal:  J Mol Med (Berl)       Date:  2018-08-23       Impact factor: 4.599

6.  Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.

Authors:  Amy S Farrell; Carl Pelz; Xiaoyan Wang; Colin J Daniel; Zhiping Wang; Yulong Su; Mahnaz Janghorban; Xiaoli Zhang; Charlie Morgan; Soren Impey; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

Review 7.  Polycomb group proteins and MYC: the cancer connection.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Cell Mol Life Sci       Date:  2013-07-30       Impact factor: 9.261

Review 8.  MYC degradation.

Authors:  Amy S Farrell; Rosalie C Sears
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

9.  BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma.

Authors:  Joydeep Bhadury; Lisa M Nilsson; Somsundar Veppil Muralidharan; Lydia C Green; Zhoulei Li; Emily M Gesner; Henrik C Hansen; Ulrich B Keller; Kevin G McLure; Jonas A Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

Review 10.  Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy.

Authors:  Xiao-Xin Sun; Yanping Li; Rosalie C Sears; Mu-Shui Dai
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.